APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immune Health Ingredient

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immune Health Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchImmune Health Ingredient Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Immune Health Ingredient Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Immune Health Ingredient Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immune Health Ingredient Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Immune Health Ingredient Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Immune Health Ingredient market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immune Health Ingredient is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immune Health Ingredient include ADM, Arla Foods, Associated British Foods, Balchem, Cargill, Chr. Hansen, Divis Laboratories, DSM and Glanbia PLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immune Health Ingredient market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune Health Ingredient and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune Health Ingredient sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immune Health Ingredient market size, projected growth trends, production technologies, key applications, and end-use industries.

Immune Health Ingredient Segment by Company

ADM

Arla Foods

Associated British Foods

Balchem

Cargill

Chr. Hansen

Divis Laboratories

DSM

Glanbia PLC

Ingredion

International Flavors & Fragrances

Kerry Group PLC

MartinBauer

Roquette

ROYAL FRIESLANDCAMPINA N.V.

Tate & Lyle

BASF

Fonterra

Lonza

Probi

Immune Health Ingredient Segment by Type

Plant & Fruit Extracts

Nutritional Lipids

Prebiotics

Probiotic Starter Cultures

Vitamins

Minerals

Enzymes

Functional Carbohydrates

Proteins

Immune Health Ingredient Segment by Application

Beverages

Pharmaceuticals

Feed

Food

Others

Immune Health Ingredient Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Ingredient market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune Health Ingredient and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Ingredient.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immune Health Ingredient market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immune Health Ingredient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Immune Health Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Immune Health Ingredient in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Immune Health Ingredient Industry Trends Table 2. Immune Health Ingredient Industry Drivers Table 3. Immune Health Ingredient Industry Opportunities and Challenges Table 4. Immune Health Ingredient Industry Restraints Table 5. Global Immune Health Ingredient Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Immune Health Ingredient Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Immune Health Ingredient Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Immune Health Ingredient Sales Market Share by Manufacturers Table 9. Global Immune Health Ingredient Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Immune Health Ingredient Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Immune Health Ingredient Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Immune Health Ingredient Manufacturers, Product Type & Application Table 13. Global Immune Health Ingredient Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Immune Health Ingredient by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Plant & Fruit Extracts Table 17. Major Manufacturers of Nutritional Lipids Table 18. Major Manufacturers of Prebiotics Table 19. Major Manufacturers of Probiotic Starter Cultures Table 20. Major Manufacturers of Vitamins Table 21. Major Manufacturers of Minerals Table 22. Major Manufacturers of Enzymes Table 23. Major Manufacturers of Functional Carbohydrates Table 24. Major Manufacturers of Proteins Table 25. Global Immune Health Ingredient Sales by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Immune Health Ingredient Sales by Type (2021-2026) & (k units) Table 27. Global Immune Health Ingredient Sales by Type (2027-2032) & (k units) Table 28. Global Immune Health Ingredient Sales Market Share by Type (2021-2026) Table 29. Global Immune Health Ingredient Sales Market Share by Type (2027-2032) Table 30. Global Immune Health Ingredient Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 31. Global Immune Health Ingredient Revenue by Type (2021-2026) & (k units) Table 32. Global Immune Health Ingredient Revenue by Type (2027-2032) & (k units) Table 33. Global Immune Health Ingredient Revenue Market Share by Type (2021-2026) Table 34. Global Immune Health Ingredient Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Beverages Table 36. Major Manufacturers of Pharmaceuticals Table 37. Major Manufacturers of Feed Table 38. Major Manufacturers of Food Table 39. Major Manufacturers of Others Table 40. Global Immune Health Ingredient Sales by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Immune Health Ingredient Sales by Application (2021-2026) & (k units) Table 42. Global Immune Health Ingredient Sales by Application (2027-2032) & (k units) Table 43. Global Immune Health Ingredient Sales Market Share by Application (2021-2026) Table 44. Global Immune Health Ingredient Sales Market Share by Application (2027-2032) Table 45. Global Immune Health Ingredient Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 46. Global Immune Health Ingredient Revenue by Application (2021-2026) & (k units) Table 47. Global Immune Health Ingredient Revenue by Application (2027-2032) & (k units) Table 48. Global Immune Health Ingredient Revenue Market Share by Application (2021-2026) Table 49. Global Immune Health Ingredient Revenue Market Share by Application (2027-2032) Table 50. Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 51. Global Immune Health Ingredient Sales by Region (2021-2026) & (k units) Table 52. Global Immune Health Ingredient Sales Market Share by Region (2021-2026) Table 53. Global Immune Health Ingredient Sales Forecasted by Region (2027-2032) & (k units) Table 54. Global Immune Health Ingredient Sales Forecasted Market Share by Region (2027-2032) Table 55. North America Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. North America Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 57. North America Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 58. Europe Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Europe Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 60. Europe Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 61. Asia Pacific Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 62. Asia Pacific Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 63. Asia Pacific Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 64. South America, Middle East and Africa Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 65. South America, Middle East and Africa Immune Health Ingredient Sales by Country (2021-2026) & (k units) Table 66. South America, Middle East and Africa Immune Health Ingredient Sales by Country (2027-2032) & (k units) Table 67. Global Immune Health Ingredient Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 68. Global Immune Health Ingredient Revenue by Region (2021-2026) & (US$ Million) Table 69. Global Immune Health Ingredient Revenue by Region (2027-2032) & (US$ Million) Table 70. Global Immune Health Ingredient Revenue Market Share by Region (2021-2026) Table 71. Global Immune Health Ingredient Revenue Market Share by Region (2027-2032) Table 72. ADM Company Information Table 73. ADM Business Overview Table 74. ADM Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. ADM Immune Health Ingredient Product Portfolio Table 76. ADM Recent Development Table 77. Arla Foods Company Information Table 78. Arla Foods Business Overview Table 79. Arla Foods Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Arla Foods Immune Health Ingredient Product Portfolio Table 81. Arla Foods Recent Development Table 82. Associated British Foods Company Information Table 83. Associated British Foods Business Overview Table 84. Associated British Foods Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Associated British Foods Immune Health Ingredient Product Portfolio Table 86. Associated British Foods Recent Development Table 87. Balchem Company Information Table 88. Balchem Business Overview Table 89. Balchem Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Balchem Immune Health Ingredient Product Portfolio Table 91. Balchem Recent Development Table 92. Cargill Company Information Table 93. Cargill Business Overview Table 94. Cargill Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Cargill Immune Health Ingredient Product Portfolio Table 96. Cargill Recent Development Table 97. Chr. Hansen Company Information Table 98. Chr. Hansen Business Overview Table 99. Chr. Hansen Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Chr. Hansen Immune Health Ingredient Product Portfolio Table 101. Chr. Hansen Recent Development Table 102. Divis Laboratories Company Information Table 103. Divis Laboratories Business Overview Table 104. Divis Laboratories Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Divis Laboratories Immune Health Ingredient Product Portfolio Table 106. Divis Laboratories Recent Development Table 107. DSM Company Information Table 108. DSM Business Overview Table 109. DSM Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. DSM Immune Health Ingredient Product Portfolio Table 111. DSM Recent Development Table 112. Glanbia PLC Company Information Table 113. Glanbia PLC Business Overview Table 114. Glanbia PLC Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Glanbia PLC Immune Health Ingredient Product Portfolio Table 116. Glanbia PLC Recent Development Table 117. Ingredion Company Information Table 118. Ingredion Business Overview Table 119. Ingredion Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Ingredion Immune Health Ingredient Product Portfolio Table 121. Ingredion Recent Development Table 122. International Flavors & Fragrances Company Information Table 123. International Flavors & Fragrances Business Overview Table 124. International Flavors & Fragrances Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. International Flavors & Fragrances Immune Health Ingredient Product Portfolio Table 126. International Flavors & Fragrances Recent Development Table 127. Kerry Group PLC Company Information Table 128. Kerry Group PLC Business Overview Table 129. Kerry Group PLC Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Kerry Group PLC Immune Health Ingredient Product Portfolio Table 131. Kerry Group PLC Recent Development Table 132. MartinBauer Company Information Table 133. MartinBauer Business Overview Table 134. MartinBauer Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. MartinBauer Immune Health Ingredient Product Portfolio Table 136. MartinBauer Recent Development Table 137. Roquette Company Information Table 138. Roquette Business Overview Table 139. Roquette Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Roquette Immune Health Ingredient Product Portfolio Table 141. Roquette Recent Development Table 142. ROYAL FRIESLANDCAMPINA N.V. Company Information Table 143. ROYAL FRIESLANDCAMPINA N.V. Business Overview Table 144. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio Table 146. ROYAL FRIESLANDCAMPINA N.V. Recent Development Table 147. Tate & Lyle Company Information Table 148. Tate & Lyle Business Overview Table 149. Tate & Lyle Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Tate & Lyle Immune Health Ingredient Product Portfolio Table 151. Tate & Lyle Recent Development Table 152. BASF Company Information Table 153. BASF Business Overview Table 154. BASF Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. BASF Immune Health Ingredient Product Portfolio Table 156. BASF Recent Development Table 157. Fonterra Company Information Table 158. Fonterra Business Overview Table 159. Fonterra Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Fonterra Immune Health Ingredient Product Portfolio Table 161. Fonterra Recent Development Table 162. Lonza Company Information Table 163. Lonza Business Overview Table 164. Lonza Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. Lonza Immune Health Ingredient Product Portfolio Table 166. Lonza Recent Development Table 167. Probi Company Information Table 168. Probi Business Overview Table 169. Probi Immune Health Ingredient Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. Probi Immune Health Ingredient Product Portfolio Table 171. Probi Recent Development Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Immune Health Ingredient Distributors List Table 175. Immune Health Ingredient Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Immune Health Ingredient Product Image Figure 2. Global Immune Health Ingredient Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune Health Ingredient Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune Health Ingredient Sales (2021-2032) & (k units) Figure 5. Global Immune Health Ingredient Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Immune Health Ingredient Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Plant & Fruit Extracts Image Figure 9. Nutritional Lipids Image Figure 10. Prebiotics Image Figure 11. Probiotic Starter Cultures Image Figure 12. Vitamins Image Figure 13. Minerals Image Figure 14. Enzymes Image Figure 15. Functional Carbohydrates Image Figure 16. Proteins Image Figure 17. Global Immune Health Ingredient Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Immune Health Ingredient Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global Immune Health Ingredient Sales Market Share by Type (2021-2032) Figure 20. Global Immune Health Ingredient Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Immune Health Ingredient Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Immune Health Ingredient Revenue Market Share by Type (2021-2032) Figure 23. Beverages Image Figure 24. Pharmaceuticals Image Figure 25. Feed Image Figure 26. Food Image Figure 27. Others Image Figure 28. Global Immune Health Ingredient Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 29. Global Immune Health Ingredient Sales Market Share 2021 VS 2025 VS 2032 Figure 30. Global Immune Health Ingredient Sales Market Share by Application (2021-2032) Figure 31. Global Immune Health Ingredient Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Immune Health Ingredient Revenue Market Share 2021 VS 2025 VS 2032 Figure 33. Global Immune Health Ingredient Revenue Market Share by Application (2021-2032) Figure 34. North America Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 35. North America Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 36. U.S. Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 37. Canada Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 38. Mexico Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 39. Europe Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 40. Europe Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 41. Germany Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 42. France Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 43. U.K. Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 44. Italy Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 45. Netherlands Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 46. Asia Pacific Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 47. Asia Pacific Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 48. China Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 49. Japan Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Korea Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 51. Southeast Asia Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 52. India Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 53. Australia Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 54. South America, Middle East and Africa Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 55. South America, Middle East and Africa Immune Health Ingredient Sales Market Share by Country (2021-2032) Figure 56. Brazil Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 57. South Africa Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 58. Saudi Arabia Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 59. Turkey Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 60. Argentina Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 61. UAE Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 62. Egypt Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 63. Chile Immune Health Ingredient Sales and Growth Rate (2021-2032) & (k units) Figure 64. Global Immune Health Ingredient Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Global Immune Health Ingredient Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 66. North America Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Figure 67. North America Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Europe Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Figure 69. Europe Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Asia-Pacific Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Figure 71. Asia-Pacific Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. South America, Middle East and Africa Immune Health Ingredient Revenue (2021-2032) & (US$ Million) Figure 73. South America, Middle East and Africa Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 74. Immune Health Ingredient Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Immune Health Ingredient Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Plant & Fruit Extracts
  • Nutritional Lipids
  • Prebiotics
  • Probiotic Starter Cultures
  • Vitamins
  • Minerals
  • Enzymes
  • Functional Carbohydrates
  • Proteins
Applications
  • Beverages
  • Pharmaceuticals
  • Feed
  • Food
  • Others
Companies covered
  • ADM
  • Arla Foods
  • Associated British Foods
  • Balchem
  • Cargill
  • Chr. Hansen
  • Divis Laboratories
  • DSM
  • Glanbia PLC
  • Ingredion
  • International Flavors & Fragrances
  • Kerry Group PLC
  • MartinBauer
  • Roquette
  • ROYAL FRIESLANDCAMPINA N.V.
  • Tate & Lyle
  • BASF
  • Fonterra
  • Lonza
  • Probi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immune Health Ingredient Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immune Health Ingredient Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Immune Health Ingredient Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Immune Health Ingredient Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Immune Health Ingredient Market Dynamics
  1. 2.1 Immune Health Ingredient Industry Trends
  2. 2.2 Immune Health Ingredient Industry Drivers
  3. 2.3 Immune Health Ingredient Industry Opportunities and Challenges
  4. 2.4 Immune Health Ingredient Industry Restraints
3 Immune Health Ingredient Market by Manufacturers
  1. 3.1 Global Immune Health Ingredient Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Immune Health Ingredient Sales by Manufacturers (2021-2026)
  3. 3.3 Global Immune Health Ingredient Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Immune Health Ingredient Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immune Health Ingredient Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Immune Health Ingredient Manufacturers, Product Type & Application
  7. 3.7 Global Immune Health Ingredient Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immune Health Ingredient Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immune Health Ingredient Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immune Health Ingredient Tier 1, Tier 2, and Tier 3
4 Immune Health Ingredient Market by Type
  1. 4.1 Immune Health Ingredient Type Introduction
  2. 4.1.1 Plant & Fruit Extracts
  3. 4.1.2 Nutritional Lipids
  4. 4.1.3 Prebiotics
  5. 4.1.4 Probiotic Starter Cultures
  6. 4.1.5 Vitamins
  7. 4.1.6 Minerals
  8. 4.1.7 Enzymes
  9. 4.1.8 Functional Carbohydrates
  10. 4.1.9 Proteins
  11. 4.2 Global Immune Health Ingredient Sales by Type
  12. 4.2.1 Global Immune Health Ingredient Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Immune Health Ingredient Sales by Type (2021-2032)
  14. 4.2.3 Global Immune Health Ingredient Sales Market Share by Type (2021-2032)
  15. 4.3 Global Immune Health Ingredient Revenue by Type
  16. 4.3.1 Global Immune Health Ingredient Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Immune Health Ingredient Revenue by Type (2021-2032)
  18. 4.3.3 Global Immune Health Ingredient Revenue Market Share by Type (2021-2032)
5 Immune Health Ingredient Market by Application
  1. 5.1 Immune Health Ingredient Application Introduction
  2. 5.1.1 Beverages
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Feed
  5. 5.1.4 Food
  6. 5.1.5 Others
  7. 5.2 Global Immune Health Ingredient Sales by Application
  8. 5.2.1 Global Immune Health Ingredient Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Immune Health Ingredient Sales by Application (2021-2032)
  10. 5.2.3 Global Immune Health Ingredient Sales Market Share by Application (2021-2032)
  11. 5.3 Global Immune Health Ingredient Revenue by Application
  12. 5.3.1 Global Immune Health Ingredient Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Immune Health Ingredient Revenue by Application (2021-2032)
  14. 5.3.3 Global Immune Health Ingredient Revenue Market Share by Application (2021-2032)
6 Global Immune Health Ingredient Sales by Region
  1. 6.1 Global Immune Health Ingredient Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune Health Ingredient Sales by Region (2021-2032)
  3. 6.2.1 Global Immune Health Ingredient Sales by Region (2021-2026)
  4. 6.2.2 Global Immune Health Ingredient Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Immune Health Ingredient Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Immune Health Ingredient Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Immune Health Ingredient Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Immune Health Ingredient Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Immune Health Ingredient Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Immune Health Ingredient Revenue by Region
  1. 7.1 Global Immune Health Ingredient Revenue by Region
  2. 7.1.1 Global Immune Health Ingredient Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Immune Health Ingredient Revenue by Region (2021-2026)
  4. 7.1.3 Global Immune Health Ingredient Revenue by Region (2027-2032)
  5. 7.1.4 Global Immune Health Ingredient Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Immune Health Ingredient Revenue (2021-2032)
  8. 7.2.2 North America Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Immune Health Ingredient Revenue (2021-2032)
  11. 7.3.2 Europe Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Immune Health Ingredient Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Immune Health Ingredient Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Immune Health Ingredient Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ADM
  2. 8.1.1 ADM Company Information
  3. 8.1.2 ADM Business Overview
  4. 8.1.3 ADM Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ADM Immune Health Ingredient Product Portfolio
  6. 8.1.5 ADM Recent Developments
  7. 8.2 Arla Foods
  8. 8.2.1 Arla Foods Company Information
  9. 8.2.2 Arla Foods Business Overview
  10. 8.2.3 Arla Foods Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Arla Foods Immune Health Ingredient Product Portfolio
  12. 8.2.5 Arla Foods Recent Developments
  13. 8.3 Associated British Foods
  14. 8.3.1 Associated British Foods Company Information
  15. 8.3.2 Associated British Foods Business Overview
  16. 8.3.3 Associated British Foods Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Associated British Foods Immune Health Ingredient Product Portfolio
  18. 8.3.5 Associated British Foods Recent Developments
  19. 8.4 Balchem
  20. 8.4.1 Balchem Company Information
  21. 8.4.2 Balchem Business Overview
  22. 8.4.3 Balchem Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Balchem Immune Health Ingredient Product Portfolio
  24. 8.4.5 Balchem Recent Developments
  25. 8.5 Cargill
  26. 8.5.1 Cargill Company Information
  27. 8.5.2 Cargill Business Overview
  28. 8.5.3 Cargill Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cargill Immune Health Ingredient Product Portfolio
  30. 8.5.5 Cargill Recent Developments
  31. 8.6 Chr. Hansen
  32. 8.6.1 Chr. Hansen Company Information
  33. 8.6.2 Chr. Hansen Business Overview
  34. 8.6.3 Chr. Hansen Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Chr. Hansen Immune Health Ingredient Product Portfolio
  36. 8.6.5 Chr. Hansen Recent Developments
  37. 8.7 Divis Laboratories
  38. 8.7.1 Divis Laboratories Company Information
  39. 8.7.2 Divis Laboratories Business Overview
  40. 8.7.3 Divis Laboratories Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Divis Laboratories Immune Health Ingredient Product Portfolio
  42. 8.7.5 Divis Laboratories Recent Developments
  43. 8.8 DSM
  44. 8.8.1 DSM Company Information
  45. 8.8.2 DSM Business Overview
  46. 8.8.3 DSM Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 DSM Immune Health Ingredient Product Portfolio
  48. 8.8.5 DSM Recent Developments
  49. 8.9 Glanbia PLC
  50. 8.9.1 Glanbia PLC Company Information
  51. 8.9.2 Glanbia PLC Business Overview
  52. 8.9.3 Glanbia PLC Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Glanbia PLC Immune Health Ingredient Product Portfolio
  54. 8.9.5 Glanbia PLC Recent Developments
  55. 8.10 Ingredion
  56. 8.10.1 Ingredion Company Information
  57. 8.10.2 Ingredion Business Overview
  58. 8.10.3 Ingredion Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ingredion Immune Health Ingredient Product Portfolio
  60. 8.10.5 Ingredion Recent Developments
  61. 8.11 International Flavors & Fragrances
  62. 8.11.1 International Flavors & Fragrances Company Information
  63. 8.11.2 International Flavors & Fragrances Business Overview
  64. 8.11.3 International Flavors & Fragrances Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 International Flavors & Fragrances Immune Health Ingredient Product Portfolio
  66. 8.11.5 International Flavors & Fragrances Recent Developments
  67. 8.12 Kerry Group PLC
  68. 8.12.1 Kerry Group PLC Company Information
  69. 8.12.2 Kerry Group PLC Business Overview
  70. 8.12.3 Kerry Group PLC Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Kerry Group PLC Immune Health Ingredient Product Portfolio
  72. 8.12.5 Kerry Group PLC Recent Developments
  73. 8.13 MartinBauer
  74. 8.13.1 MartinBauer Company Information
  75. 8.13.2 MartinBauer Business Overview
  76. 8.13.3 MartinBauer Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MartinBauer Immune Health Ingredient Product Portfolio
  78. 8.13.5 MartinBauer Recent Developments
  79. 8.14 Roquette
  80. 8.14.1 Roquette Company Information
  81. 8.14.2 Roquette Business Overview
  82. 8.14.3 Roquette Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Roquette Immune Health Ingredient Product Portfolio
  84. 8.14.5 Roquette Recent Developments
  85. 8.15 ROYAL FRIESLANDCAMPINA N.V.
  86. 8.15.1 ROYAL FRIESLANDCAMPINA N.V. Company Information
  87. 8.15.2 ROYAL FRIESLANDCAMPINA N.V. Business Overview
  88. 8.15.3 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ROYAL FRIESLANDCAMPINA N.V. Immune Health Ingredient Product Portfolio
  90. 8.15.5 ROYAL FRIESLANDCAMPINA N.V. Recent Developments
  91. 8.16 Tate & Lyle
  92. 8.16.1 Tate & Lyle Company Information
  93. 8.16.2 Tate & Lyle Business Overview
  94. 8.16.3 Tate & Lyle Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Tate & Lyle Immune Health Ingredient Product Portfolio
  96. 8.16.5 Tate & Lyle Recent Developments
  97. 8.17 BASF
  98. 8.17.1 BASF Company Information
  99. 8.17.2 BASF Business Overview
  100. 8.17.3 BASF Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 BASF Immune Health Ingredient Product Portfolio
  102. 8.17.5 BASF Recent Developments
  103. 8.18 Fonterra
  104. 8.18.1 Fonterra Company Information
  105. 8.18.2 Fonterra Business Overview
  106. 8.18.3 Fonterra Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Fonterra Immune Health Ingredient Product Portfolio
  108. 8.18.5 Fonterra Recent Developments
  109. 8.19 Lonza
  110. 8.19.1 Lonza Company Information
  111. 8.19.2 Lonza Business Overview
  112. 8.19.3 Lonza Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Lonza Immune Health Ingredient Product Portfolio
  114. 8.19.5 Lonza Recent Developments
  115. 8.20 Probi
  116. 8.20.1 Probi Company Information
  117. 8.20.2 Probi Business Overview
  118. 8.20.3 Probi Immune Health Ingredient Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Probi Immune Health Ingredient Product Portfolio
  120. 8.20.5 Probi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immune Health Ingredient Value Chain Analysis
  2. 9.1.1 Immune Health Ingredient Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immune Health Ingredient Production Mode & Process
  6. 9.2 Immune Health Ingredient Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immune Health Ingredient Distributors
  9. 9.2.3 Immune Health Ingredient Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst